CMV FINANCEMENT VEHICULE

COMMUNIQUÉS West-GlobeNewswire

Apricus Biosciences Announces Corporate Update and Second Quarter 2017 Financial Results Conference Call
26/07/2017
SAN DIEGO, July 26, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Apricus' second quarter [...]
Gap In Perceived and Actual Rates Of Prescription Stimulant Misuse, Abuse and Diversion Found Among College Students
26/07/2017
Gap In Perceived and Actual Rates Of Prescription S timulant Misuse, Abuse and Diversion Found Among College Students Preliminary analysis of data shows association between non-medical use of prescription stimulants and [...]
Midatech Pharma Plc: Completion of pre-clinical liver cancer programme
26/07/2017
26 July 2017 Midatech Pharma PLC ("Midatech", "Company" or "Group") Completion of pre-clinical liver cancer programme Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused [...]
Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment
26/07/2017
Dose escalation trial will evaluate RPL554 in approximately 400 COPD patients LONDON, July 26, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical [...]
ABLYNX RECEIVES FAST TRACK DESIGNATION FROM THE FDA FOR CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP
26/07/2017
GHENT, Belgium, 26 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for caplacizumab, the Company's first-in- [...]
Össur hf: Q2 Results 2017
25/07/2017
Announcement no. 52/2017 Interim report for the first six months of 2017 25 July 2017 Össur Q2 2017 highlights Sales amounted to USD 145 million compared to USD 139 million in Q2 2016, corresponding to 6% growth and 3% [...]
Medasys - Son expansion internationale soulignée par l'étude de marché KLAS
25/07/2017
Etude de renommée internationale, l'analyse menée par l'institut de recherche américain KLAS, porte sur l'acquisition et le déploiement des dossiers patients informatisés (DPI) à l'échelle mondiale (hors Etats-Unis). [...]
Corning and Stevanato Group Enter New Agreement to Supply New Corning Valor(TM) Glass to the Pharmaceutical Packaging Market
25/07/2017
Remarkable glass innovation enables enhanced quality parenteral packaging CORNING, N.Y., and PIOMBINO, DESE, PADUA, Italy; JULY 25, 2017 - Corning Incorporated (NYSE: GLW) and Stevanato Group announced today a new [...]
Oriola Corporation - Repurchase of own shares on 25 July 2017
25/07/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 25 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 25 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 13,485 Average price/share, EUR 3,5553 Total [...]
RedHill Biopharma Reports 2017 Second Quarter Financial Results
25/07/2017
RedHill maintains a debt-free balance sheet with $51 million cash 1 at the end of the second quarter of 2017 Select recent milestones include: Initial net revenues of approximately $0.5 million between June 12-30 [...]
Virbac : bilan semestriel contrat de liquidité au 30 juin 2017
25/07/2017
Carros, le 5 juillet 2017 BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société VIRBAC S.A. à la société EXANE BNP PARIBAS, les moyens suivants figuraient au [...]
Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call
25/07/2017
Heidelberg, Germany, July 25, 2017 - Affimed N.V. (Nasdaq: AFMD) today announced that on August 1, 2017, the Company will release its financial results for the quarter ended June 30, 2017. The Company's management team [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
25/07/2017
FIT Biotech Oy Company release July 25, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries
25/07/2017
Expanded partnership to help "even the odds" of survival for children with cancer in the Philippines, Myanmar, Mexico and Ghana In developed countries, the survival rate for childhood cancer is 80%, while in developing [...]
Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
24/07/2017
Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response New data demonstrate that Novavax' construct [...]
Communiqué : Point sur l'obtention des autorisations des autorités de la concurrence dans le cadre du projet de rapprochement entre Essilor et Luxottica
24/07/2017
Point sur l'obtention des autorisations des autorités de la concurrence dans le cadre du projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 24 [...]
News Release: Antitrust process update for the proposed combination between Essilor and Luxottica
24/07/2017
Antitrust process update for the proposed combination between Essilor and Luxottica PDF Version of the news release Charenton-le-Pont, France and Milan, Italy (July 24, 2017) - The proposed combination between Essilor ( [...]
Ossur Hf : Transactions in relation to share buyback program
24/07/2017
Announcement from Össur hf. No. 51/2017 Reykjavík, 24 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Oriola Corporation - Repurchase of own shares on 24 July 2017
24/07/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 24 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 24 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 16.657 Average price/share, EUR 3,5601 Total [...]

Pages